Eyepoint, Inc. · NASDAQ:EYPT

Paradigm Biocapital Advisors LP reported a 5.10% stake in Eyepoint, Inc. (Schedule 13G)

Event Feb 17, 2026 · Filed Feb 24, 2026

Paradigm Biocapital Advisors LP reported a 5.10% stake in Eyepoint, Inc., 4,192,261 shares, as a passive investor on Feb 17, 2026. Filed Feb 24, 2026 (Schedule 13G).

Stake
5.10%
Shares
4,192,261
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Paradigm BioCapital Advisors LP5.10%4,192,261
Paradigm BioCapital Advisors GP LLC5.10%4,192,261
Senai Asefaw, M.D.5.10%4,192,261
Paradigm BioCapital International Fund Ltd.4.50%3,694,542

Source

View original at SEC

Related